|
Metalloreductase STEAP1 (102-116)
|
|
|
|
melanoma-overexpressed antigen 1 (24-37)
|
|
|
|
melanoma-overexpressed antigen 1 (36-44)
|
|
|
|
melanoma-overexpressed antigen 1 (31-44)
|
|
|
|
Midkine (114-122)
|
|
|
|
mTERT (572-580)
|
|
|
|
Midkine (9-23)
|
|
|
|
Microsomal glutathione S-transferase 1 isoform a (121-132)
|
|
|
|
Microtubule-associated protein 1A (806-814)
|
|
|
|
MGAT5 (intro)
|
|
|
|
Moth Cytochrome C (MCC) 88-103
|
|
108273-68-3
|
|
Midkine (13-21)
|
|
|
|
MUC5AC motif peptide
|
|
|
|
Midasin (1471-1481)
|
|
|
|
MLH3 protein, partial (135-151)
|
|
|
|
mTRP-2 (180-188)
|
|
219312-69-3
|
|
NAD-dependent protein deacetylase sirtuin-2 (192-200)
|
|
|
|
NADP-dependent malic enzyme (224-232)
|
|
|
|
NUAK family SNF1-like kinase 2 (446-455)
|
|
|
|
Mucin-1 (950-958)
|
|
|
|
Murine Survivin (20-28)
|
|
|
|
Mucin-1 precursor (12-20)
|
|
|
|
Mucin-5AC (716-724)
|
|
|
|
Metalloreductase STEAP1 (292-300)
|
|
|
|
Murine Survivin (97-104)
|
|
|
|
Mucin-1 (repeated region)
|
|
|
|
PAP-3 (135-143)
|
|
|
|
Perilipin-2 (129-137)
|
|
|
|
OVA (241-270)
|
|
|
|
Peroxiredoxin-5, mitochondrial (163-172)
|
|
|
|
NY-ESO-1 (161-180)
|
|
|
|
p53 (139-147)
|
|
|
|
N-terminally acetylated Endomorphin-1
|
|
|
|
MUM3 (322-330)
|
|
|
|
NY-CO-13 (187-197)
|
|
|
|
Nucleoprotein (265-273)
|
|
|
|
PACAP-Related Peptide (PRP), human
|
|
|
|
NY-ESO-1 (155-163)
|
|
|
|
Nuclear transcription factor Y subunit gamma (275-282)
|
|
|
|
NY-ESO-1 peptide (1-9)
|
|
|
|
Paired box protein Pax-5 (311-319)
|
|
|
|
Nuclear transcription factor Y subunit gamma (28-37)
|
|
|
|
Nucleoprotein 396-404
|
|
158475-79-7
|
|
Nucleoprotein 118-126
|
|
124454-83-7
|
|
NY-ESO-1 (157-165)
|
|
|
|
NY-CO-13 (139-147)
|
|
|
|
(Prolyl-hydroxylprolyl-glycine)10
|
|
40350-90-1
|
|
Prostate Specific Antigen-1 (153-161)
|
|
|
|
Prostate-specific antigen (178-187)
|
|
|
|
Prostate Specific Antigen (146-154)
|
|
|
|
Prostate-specific antigen (165-174)
|
|
|
|
Nuclear pore complex protein Nup98 (315-360)
|
|
|
|
papillomavirus binding factor (499-510)
|
|
|
|
p14ARF-ORF3 (125-133)
|
|
|
|
p53 (149-157)
|
|
|
|
p53 (103-111)
|
|
|
|
Programmed cell death 1 ligand 1 (15-23)
|
|
|
|
Prohormone Convertase 2
|
|
|
|
Poly(A) polymerase gamma (724-734)
|
|
|
|
Procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 (388-401)
|
|
|
|
PMEL (25-33)
|
|
|
|
Phe-CO-Arg-Val-DPhe
|
|
83830-01-7
|
|
Polypyrimidine tract-binding protein 1 isoform b (359-373)
|
|
|
|
POTE ankyrin domain family member F (795-804)
|
|
|
|
Polycystic kidney disease 1 protein (4192-4202)
|
|
|
|
Protein enabled homolog (443-451)
|
|
|
|
Protein SSX2 (41-49)
|
|
|
|
Protein SSX2 (101-111)
|
|
|
|
Prostatic acid phosphatase (18-26)
|
|
|
|
Protein SSX4 (151-170)
|
|
|
|
Protein SSX2 (45-59)
|
|
|
|
Prostatic acid phosphatase (112-120)
|
|
|
|
Protein SSX2 (45-58)
|
|
|
|
Protein SSX2 (19-34)
|
|
|
|
Protein OS-9 (438-446)
|
|
|
|
Protein enabled homolog (502-510)
|
|
|
|
Protein phosphatase 1 regulatory subunit 3B (172-180)
|
|
|
|
Prostatic acid phosphatase (299-307)
|
|
|
|
Rabenosyn-5 (541-552)
|
|
|
|
Putative protein product of HMFN1045 (253-264)
|
|
|
|
Protein SSX2 (37-54)
|
|
|
|
Receptor-type tyrosine-protein kinase FLT3 (591-600)
|
|
|
|
PSMA-PEG4
|
|
2256069-92-6
|
|
Receptor-type tyrosine-protein phosphatase kappa (667-682)
|
|
|
|
(R)-2-hydroxy-3-(2-methylphenyl)-propionic acid
|
|
1932808-80-4
|
|
PSMA (27-38)
|
|
|
|
Ras-related protein Rab-38 (50-58)
|
|
|
|
PSMA/PSM-P1 (4-12)
|
|
|
|
[pThr3]-CDK5 Substrate
|
|
1670273-47-8
|
|
Protein SSX4 (31-50)
|
|
|
|
Protein SSX4 (61-80)
|
|
|
|
PSM P2 (711-719)
|
|
|
|
Protein SSX4 (51-70)
|
|
|
|
Protein SSX4 (41-60)
|
|
|
|
Ras-related protein Rab-27A (178-186)
|
|
|
|
Proto-oncogene PIM1 (191-199)
|
|
|
|
Protein SSX4 (161-180)
|
|
|
|
[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor 1142-1153
|
|
141171-54-2
|
|
PSCA (14-22)
|
|
|
|
Protein timeless homolog (848-856)
|
|
|